Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| Mueller cell | 6 studies | 79% ± 18% | |
| astrocyte | 5 studies | 29% ± 8% | |
| retinal pigment epithelial cell | 4 studies | 84% ± 12% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| eye | 5 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 95% | 419.50 | 2516 / 2642 | 93% | 11.36 | 655 / 705 |
| eye | 0% | 0 | 0 / 0 | 89% | 24.47 | 71 / 80 |
| skin | 0% | 0.54 | 2 / 1809 | 81% | 37.55 | 384 / 472 |
| intestine | 57% | 76.22 | 552 / 966 | 11% | 0.51 | 57 / 527 |
| stomach | 19% | 16.01 | 68 / 359 | 9% | 0.67 | 25 / 286 |
| esophagus | 10% | 5.52 | 138 / 1445 | 8% | 0.49 | 15 / 183 |
| bladder | 0% | 0 | 0 / 21 | 7% | 0.31 | 37 / 504 |
| breast | 0% | 0 | 0 / 459 | 6% | 0.64 | 71 / 1118 |
| uterus | 0% | 0 | 0 / 170 | 5% | 0.20 | 25 / 459 |
| adrenal gland | 2% | 1.19 | 5 / 258 | 2% | 0.03 | 4 / 230 |
| lung | 0% | 0.15 | 1 / 578 | 3% | 0.15 | 38 / 1155 |
| pancreas | 0% | 0 | 0 / 328 | 2% | 0.10 | 4 / 178 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.05 | 1 / 45 |
| muscle | 1% | 0.54 | 9 / 803 | 0% | 0 | 0 / 0 |
| ovary | 0% | 0 | 0 / 180 | 1% | 0.02 | 4 / 430 |
| blood vessel | 1% | 0.61 | 12 / 1335 | 0% | 0 | 0 / 0 |
| kidney | 0% | 0 | 0 / 89 | 1% | 0.03 | 8 / 901 |
| peripheral blood | 1% | 0.43 | 8 / 929 | 0% | 0 | 0 / 0 |
| prostate | 0% | 0.21 | 1 / 245 | 0% | 0.00 | 1 / 502 |
| liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 2 / 406 |
| spleen | 0% | 0.17 | 1 / 241 | 0% | 0 | 0 / 0 |
| thymus | 0% | 0 | 0 / 653 | 0% | 0.01 | 2 / 605 |
| heart | 0% | 0.10 | 2 / 861 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0.06 | 1 / 1204 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007601 | Biological process | visual perception |
| GO_0006776 | Biological process | vitamin A metabolic process |
| GO_0044297 | Cellular component | cell body |
| GO_0005813 | Cellular component | centrosome |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_1902936 | Molecular function | phosphatidylinositol bisphosphate binding |
| GO_0019841 | Molecular function | retinol binding |
| GO_0005502 | Molecular function | 11-cis retinal binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | RLBP1 |
| Protein name | Retinaldehyde-binding protein 1 (Cellular retinaldehyde-binding protein) Retinaldehyde binding protein 1 |
| Synonyms | CRALBP |
| Description | FUNCTION: Soluble retinoid carrier essential the proper function of both rod and cone photoreceptors. Participates in the regeneration of active 11-cis-retinol and 11-cis-retinaldehyde, from the inactive 11-trans products of the rhodopsin photocycle and in the de novo synthesis of these retinoids from 11-trans metabolic precursors. The cycling of retinoids between photoreceptor and adjacent pigment epithelium cells is known as the 'visual cycle'. . |
| Accessions | ENST00000567787.1 P12271 H3BN92 ENST00000563254.1 H3BTN3 ENST00000268125.10 |